# Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study

> **NCT06953076** · — · RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 111 (estimated)

## Conditions studied

- Uterine Bleeding
- Uterine Leiomyomas
- Uterine Hemorrhage
- Uterine Neoplasms

## Interventions

- **DRUG:** Relugolix/estradiol/norethisterone acetate

## Key facts

- **NCT ID:** NCT06953076
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-02
- **Primary completion:** 2026-05-02
- **Final completion:** 2027-05-02
- **Target enrollment:** 111 (ESTIMATED)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06953076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06953076, "Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06953076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*